Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
The article presents current data on the effect of drugs for the treatment of gout on the composition and function of the intestinal microbiota. The potential possibilities of pre- and probiotics use for the prevention and complex therapy of gout are discussed, therapeutic effect may be associated w...
Main Authors: | M. S. Eliseev, E. N. Kharlamova, O. V. Zhelyabina, A. M. Lila |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2022-12-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1366 |
Similar Items
-
Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part I: the current state of the problem
by: M. S. Eliseev, et al.
Published: (2022-10-01) -
Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01) -
Commentaries on the updated American College of Rheumatology guidelines for the management of gout. Urate-lowering drugs (Part 1)
by: M. S. Eliseev
Published: (2020-09-01) -
ACR management guidelines for the treatment of gout: What’s new and what’s controversial
by: M. S. Eliseev
Published: (2021-05-01) -
Pharmacotherapy of gout – modern approaches and prospects
by: P. A. Lebedev, et al.
Published: (2021-08-01)